retatrutide safety clinical trial A new from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes Unapproved weight-loss drug "reta" sold

Obesity Research , 6(2), 97106.

But there's something else brewing a potential connection to mental health, specifically depression

use of therapies with potentially significant muscle effects (for example, androgens, insulin-like growth factor, growth hormone, systemic beta-agonists, neurotoxins or muscle relaxants or muscle-enhancing supplements) in any form within 3 months prior to screening

Potential complications include eyelid malposition, ectropion, prolonged edema, and scarring

Always consult a licensed healthcare provider with any medical questions or concerns

One-day shipping is standard, and tracking is available through both email and the Noom app